Selecting a Compound for Drug Development – The Importance of Knowledge Management

  • White Paper

🌐 White Paper Alert: We analyze the decision-making process for one specific aspect of drug discovery – the choice to move forward with the development of a new drug compound.

Read White Paper: Selecting a Compound for Drug Development: The Importance of Knowledge Management

Discover how a robust knowledge management system can streamline processes, organize crucial data, and bring valuable insights to the forefront.

  • Explore best practices for assembling cross-functional teams.
  • Learn to develop a concise rationale for your proposed plans.
  • Establish a framework for future decisions aligned with company goals.

Stay ahead in the dynamic world of drug discovery – download now and empower your team with the knowledge they need for impactful decisions.

Download file

Please register below to access the full content

Member Sign in

Access your saved articles, exclusive insights, and personalized recommendations.

Welcome back, your personalized
learning experience awaits.

Gain full access to exclusive resources, webinars, and insights designed to help you grow and stay ahead.

  • Access exclusive research, whitepapers & case studies
  • Attend member-only webinars and live events
  • Get early invitations to expert roundtables and workshops
  • Save and organize your favorite resources
  • Receive personalized recommendations based on your interests
  • Join a community of professionals and innovators

Stay informed. Stay connected. Stay ahead.

Published by: Doug Foster

Doug Foster, COO of inThought Labs, drives inVision’s growth with AI/ML innovation. MIT graduate with experience in startups, consulting, and global learning leadership at InterSystems and Boston Scientific.

Related Resources

  • Gated

Staying Organized at a Medical Congress: What Actually Holds Up in the Real World

Over the past two decades, we’ve supported Medical Affairs and MSL teams at hundreds of

Read More

MSL as Human in the Middle

Over the past several years, we’ve had dozens of conversations with Medical Science Liaisons who

Read More

InThought Labs builds JP Morgan Conference AI to cut through the hype

Forget their takeaways. Get Yours! 330+ companies presented at JPM 2025. Everyone’s writing what they

Read More

Contact us

Learn how inThought Labs can simplify your life and empower your team with expert consultants and our cloud-based system, inVision.

Chris Martin

President

As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.

 

With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.

 

Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.